Related Experiment Video
Updated: May 30, 2025
04:59
Cheek Injection Model for Simultaneous Measurement of Pain and Itch-related Behaviors
Published on: September 27, 2019
12.1K
Topical Medications for Chronic Itch in Older Patients: Navigating a Pressing Need
Brooke Bartley1, Christina Pierce2, Chad Hivnor3
1Department of Internal Medicine, Texas Health Presbyterian Dallas, Dallas, TX, USA.
Drugs & Aging
|January 30, 2025
Summary
Chronic itch significantly impacts older adults, stemming from various factors like aging and systemic conditions. Optimized topical treatments are crucial for managing this complex geriatric issue and minimizing adverse effects.
Area of Science:
- Geriatric Medicine
- Dermatology
- Clinical Pharmacology
Background:
- Chronic itch is a prevalent and debilitating condition in the elderly population.
- It significantly diminishes patients' quality of life.
- Causes are multifactorial, including aging, skin diseases, systemic illnesses, medications, and psychological factors.
Purpose of the Study:
- To highlight the challenges in managing chronic itch in geriatric patients.
- To emphasize the importance of optimized topical treatment strategies.
- To address the complexities arising from comorbidities and polypharmacy.
Main Methods:
- Review of existing literature on chronic itch in older adults.
- Analysis of contributing factors and treatment complexities.
- Focus on the role of topical therapies.
Main Results:
- Chronic itch in the elderly is complex due to age-related changes and multiple potential causes.
- Comorbidities and polypharmacy complicate treatment decisions.
- Topical treatments offer a vital approach to managing symptoms and preventing side effects.
Conclusions:
- Effective management of chronic itch in older patients requires a comprehensive approach.
- Optimized topical regimens are essential for improving patient outcomes.
- Addressing the unique challenges of geriatric populations is key to successful treatment.
Related Concept Videos
01:23Local Anesthetics: Common Agents and Their Applications
396
Local anesthetics (LAs) are commonly used for various applications in medical and dental procedures. Some of the common agents used are cocaine, lidocaine, and bupivacaine.
Cocaine is an ester of benzoic acid and methylecgogine. It is used to anesthetize and vasoconstrict locally. Currently, it is used primarily for topical applications. It is beneficial for surgeries on the upper respiratory tract, providing anesthesia and shrinking the mucosa. Cocaine in the form of cocaine hydrochloride is...
Cocaine is an ester of benzoic acid and methylecgogine. It is used to anesthetize and vasoconstrict locally. Currently, it is used primarily for topical applications. It is beneficial for surgeries on the upper respiratory tract, providing anesthesia and shrinking the mucosa. Cocaine in the form of cocaine hydrochloride is...
396
01:23Hand hygiene
3.1K
Asepsis is the practice of preventing or breaking the chain of infection. The nurse employs aseptic techniques to prevent the spread of microorganisms and reduce the risk of diseases. Hand hygiene is the cornerstone of aseptic techniques and is classified into medical and surgical asepsis. Medical asepsis includes hand hygiene and the use of gloves. Surgical asepsis, or the sterile technique, refers to practices that render and keep objects and areas free of microorganisms.
Hand washing...
Hand washing...
3.1K
01:22Drug Delivery: Miscellaneous Routes
305
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
305
01:24Cholinergic Antagonists: Pharmacokinetics
407
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
407
01:26Cholinergic Antagonists: Therapeutic Uses
705
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
705
01:17Drugs for Treatment of Diarrhea-Predominant IBS
142
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
142